0
Nuvalent, Inc. Banner Image

Nuvalent, Inc.

  • Ticker NUVL
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Nuvalent, Inc. Logo Image
  • 11-50 Employees
  • Based in Cambridge, Massachusetts
Nuvalent is creating precisely targeted therapies for patients with cancer designed to overcome the limitations of existing therapies for clinically proven kinase targets. Leveraging deep expertise in structure-based design, Nuvalent develops innovative small molecules with exquisite target selectivity to overcome resistance, minimize adverse events, and drive more durable responses. NuvalentMore is advancing a robust pipeline with parallel lead programs in ROS1-positive and ALK-positive NSCLC, along with multiple discovery-stage research programs.
Nuvalent, Inc.

Most Recent Annual Report

Nuvalent, Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Nuvalent, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!